Completed
A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies
NCT03198650
- Conditions
- Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL
- Locations
-
- Research Site Chiba, Japan
- Research Site Chūōku, Japan
- Research Site Fukuoka, Japan
- Research Site Isehara-shi, Japan